Jerry Avorn
Jerry Avorn publishes mostly in Economics and Econometrics, Pharmacology and Cardiology and Cardiovascular Medicine, on topics such as Health Systems, Economic Evaluations, Quality of Life, Pharmaceutical Economics and Policy and Pharmaceutical industry and healthcare.
- World rank
- #15,031 of 7,710,434 ranked researchers
- Rank in United States
- #5,312 of 1,627,098
- Works
- 661
- Citations
- 53k
- Citations per work
- 80.5
What does Jerry Avorn research?
Jerry Avorn's work is mostly in Economics, Econometrics and Finance (19%), Medicine (15%), Pharmacology, Toxicology and Pharmaceutics (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else36555.2%
- Health Sciences12919.5%
- Medicine10015.2%
- Health Professions284.3%
- Social Sciences12619.0%
- Life Sciences426.3%
- 1Economics and Econometrics19% of their works
- 2Pharmacology6% of their works
- 3Cardiology and Cardiovascular Medicine6% of their works
- 4Geriatrics and Gerontology5% of their works
- 5Family Practice5% of their works
- 6General Health Professions4% of their works
Research topics
- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical Economics and Policy
- Pharmaceutical industry and healthcare
- Medication Adherence and Compliance
- Pharmaceutical Practices and Patient Outcomes
- Pharmaceutical studies and practices
- Pharmacovigilance and Adverse Drug Reactions
- Advanced Causal Inference Techniques
Which keywords describe Jerry Avorn's research?
The keywords of their largest research topics: Pharmaceutical Industry, Cost-effectiveness Analysis, Quality of Life, Clinical Trials, Drug Development Costs, Generic Drugs, Medication Adherence and Conflict of Interest.
- Propensity Score
- Signal Detection
- Pediatric Pharmacokinetics
- Polypharmacy
- Treatment Adherence
- Adverse Drug Reactions
- Conflict of Interest
- Generic Drugs
- Clinical Trials
- Cost-effectiveness Analysis
- Pharmaceutical Industry
- Quality of Life
- Drug Development Costs
- Medication Adherence
- Research Outcome
- Patient Compliance
- Inappropriate Medication Use
- Off-Label Drug Use
- Pharmacovigilance
- Causal Inference
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Pharmaceutical Industry2462 topics
- Cost-effectiveness Analysis1611 topic
- Quality of Life1611 topic
- Clinical Trials1602 topics
- Drug Development Costs1461 topic
- Generic Drugs1461 topic
- Medication Adherence1412 topics
- Conflict of Interest1001 topic
- Research Outcome1001 topic
- Adverse Drug Reactions982 topics
- Patient Compliance811 topic
- Treatment Adherence811 topic
- Inappropriate Medication Use791 topic
- Polypharmacy791 topic
- Off-Label Drug Use601 topic
- Pediatric Pharmacokinetics601 topic
- Pharmacovigilance381 topic
- Signal Detection381 topic
- Causal Inference351 topic
- Propensity Score351 topic
Where does Jerry Avorn work?
Jerry Avorn's main affiliation in the publication record is Brigham and Women's Hospital, United States.
How many publications and citations does Jerry Avorn have?
OpenAlex counts 661 works and 53,200 citations for Jerry Avorn, an h-index of 120, ranking #15,031 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Jerry Avorn
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Jerry Avorn. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.